Journal
PEDIATRIC BLOOD & CANCER
Volume 64, Issue 3, Pages -Publisher
WILEY
DOI: 10.1002/pbc.26288
Keywords
next-generation sequencing; oncology; precision medicine; targeted therapy
Categories
Funding
- National Human Genome Research Institute [U01HG006485]
- National Cancer Institute [UM1HG006508]
Ask authors/readers for more resources
The maturation of genomic technologies has enabled new discoveries in disease pathogenesis as well as new approaches to patient care. In pediatric oncology, patients may now receive individualized genomic analysis to identify molecular aberrations of relevance for diagnosis and/or treatment. In this context, several recent clinical studies have begun to explore the feasibility and utility of genomics-driven precision medicine. Here, we review the major developments in this field, discuss current limitations, and explore aspects of the clinical implementation of precision medicine, which lack consensus. Lastly, we discuss ongoing scientific efforts in this arena, which may yield future clinical applications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available